MITOMICINA C NEL TRATTAMENTO DEI SARCOMI DEI TESSUTI MOLLI DELL'ADULTO IN FASE AVANZATA

L. Di Lauro; A. Balice; P. Papaldo; M. Lopez

MITOMICINA C NEL TRATTAMENTO DEI SARCOMI DEI TESSUTI MOLLI DELL'ADULTO IN FASE AVANZATA

Translated title of the contribution: Mitomycin C in treatment of advanced soft-tissue sarcomata in adults

L. Di Lauro, A. Balice, P. Papaldo, M. Lopez

Istituto Regina Elena

Research output: Contribution to journal › Article › peer-review

Abstract

Mitomycin C at a dose of 20 mg/m² i.v. every 6 weeks was administered to 15 evaluable patients with measurable advanced soft tissue sarcomas resistant to standard treatment. No response was observed. Disease stabilization occurred in 5 patients, with a median duration of 4 months. Toxicity was generally mild to moderate. On the basis of this study, mitomycin C, in the dosage and schedule used in the above study, cannot be recommended in the treatment of this disease.

Translated title of the contribution	Mitomycin C in treatment of advanced soft-tissue sarcomata in adults
Original language	Italian
Pages (from-to)	83-85
Number of pages	3
Journal	Clinica Terapeutica
Volume	115
Issue number	2
Publication status	Published - 1985

ASJC Scopus subject areas

Medicine(all)

Access to Document

Fingerprint Dive into the research topics of 'Mitomycin C in treatment of advanced soft-tissue sarcomata in adults'. Together they form a unique fingerprint.

Cite this

@article{1edf2d808cb14273b92379483cc05cf2,

title = "MITOMICINA C NEL TRATTAMENTO DEI SARCOMI DEI TESSUTI MOLLI DELL'ADULTO IN FASE AVANZATA",

abstract = "Mitomycin C at a dose of 20 mg/m2 i.v. every 6 weeks was administered to 15 evaluable patients with measurable advanced soft tissue sarcomas resistant to standard treatment. No response was observed. Disease stabilization occurred in 5 patients, with a median duration of 4 months. Toxicity was generally mild to moderate. On the basis of this study, mitomycin C, in the dosage and schedule used in the above study, cannot be recommended in the treatment of this disease.",

author = "{Di Lauro}, L. and A. Balice and P. Papaldo and M. Lopez",

year = "1985",

language = "Italian",

volume = "115",

pages = "83--85",

journal = "Clinica Terapeutica",

issn = "0009-9074",

publisher = "Societa Editrice Universo",

number = "2",

}

TY - JOUR

T1 - MITOMICINA C NEL TRATTAMENTO DEI SARCOMI DEI TESSUTI MOLLI DELL'ADULTO IN FASE AVANZATA

AU - Di Lauro, L.

AU - Balice, A.

AU - Papaldo, P.

AU - Lopez, M.

PY - 1985

Y1 - 1985

N2 - Mitomycin C at a dose of 20 mg/m2 i.v. every 6 weeks was administered to 15 evaluable patients with measurable advanced soft tissue sarcomas resistant to standard treatment. No response was observed. Disease stabilization occurred in 5 patients, with a median duration of 4 months. Toxicity was generally mild to moderate. On the basis of this study, mitomycin C, in the dosage and schedule used in the above study, cannot be recommended in the treatment of this disease.

AB - Mitomycin C at a dose of 20 mg/m2 i.v. every 6 weeks was administered to 15 evaluable patients with measurable advanced soft tissue sarcomas resistant to standard treatment. No response was observed. Disease stabilization occurred in 5 patients, with a median duration of 4 months. Toxicity was generally mild to moderate. On the basis of this study, mitomycin C, in the dosage and schedule used in the above study, cannot be recommended in the treatment of this disease.

UR - http://www.scopus.com/inward/record.url?scp=0022380137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022380137&partnerID=8YFLogxK

M3 - Articolo

C2 - 3935361

AN - SCOPUS:0022380137

VL - 115

SP - 83

EP - 85

JO - Clinica Terapeutica

JF - Clinica Terapeutica

SN - 0009-9074

IS - 2

ER -